Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q2 FY26 results · Jul–Sep 2025
Divi's Laboratories reported revenue from operations of ₹2,715.00 crore (up 16.1% from Q2 FY25) and net profit of ₹689.00 crore (up 35.1% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,715.00 | 2,338.00 | +16.1% | 2,410.00 | +12.7% |
| Other income | 145.00 | 106.00 | +36.8% | 119.00 | +21.8% |
| Total income | 2,860.00 | 2,444.00 | +17.0% | 2,529.00 | +13.1% |
| Profit before tax | 912.00 | 722.00 | +26.3% | 733.00 | +24.4% |
| Net profit for the period | 689.00 | 510.00 | +35.1% | 545.00 | +26.4% |
| EPS, basic (₹) | 25.97 | 19.20 | +35.3% | 20.49 | +26.7% |
| Net margin (%) | 25.4 | 21.8 | 22.6 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,660.00 | 2,302.00 | +15.6% | 2,357.00 | +12.9% |
| Other income | 146.00 | 105.00 | +39.0% | 119.00 | +22.7% |
| Total income | 2,806.00 | 2,407.00 | +16.6% | 2,476.00 | +13.3% |
| Profit before tax | 920.00 | 735.00 | +25.2% | 747.00 | +23.2% |
| Net profit for the period | 696.00 | 518.00 | +34.4% | 557.00 | +25.0% |
| EPS, basic (₹) | 26.24 | 19.51 | +34.5% | 20.95 | +25.3% |
| Net margin (%) | 26.2 | 22.5 | 23.6 |
Consolidated
- Filed with BSE
- 07 Nov 2025, 18:13 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2025, 18:13 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE